|
Momenta receives OK for generic version of Lovenox
Houston Chronicle © 2010 AP TRENTON, NJ — Biotechnology company Momenta Pharmaceuticals Inc. said Friday the US Food and Drug Administration approved its generic version of Sanofi-Aventis SA's Lovenox, an injected drug for preventing life-threatening blood clots. … Green Light On Blood Thinner Sends Momenta 72% Higher FDA approves generic blood thinner Teva Pharma Drops On Worries Of Generic Copaxone Threat |
Related posts:
- Ranbaxy says unable to launch Flomax generic in US – Reuters
- Ranbaxy Misses Out on US Launch of Generic Flomax – Wall Street Journal
- FTC:Brand-Name, Generic Drug-Patent Settlements Rising – Wall Street Journal
- Houston jobless rate falls to 8.5 percent – Houston Chronicle
- Wal-Mart exploring options after woman wins suit – Houston Chronicle
Secured by